Alexion Pharmaceuticals names new director
6 March 2018 -

United States-based Alexion Pharmaceuticals has named Judith Reinsdorf as its director, it was reported yesterday.

Reinsdorf was earlier executive vice president and general counsel of Johnson Controls. She has a background in corporate governance and expertise in managing corporate and legal affairs and has served in various positions for companies including Tyco International and Monsanto.

David Brennan, chairman of the company's board, said, 'We are pleased to welcome Judy to Alexion's board of directors. She brings strong corporate governance and legal expertise, with a proven track records in global compliance, strategic planning, data privacy and regulatory matters. Her broad experience at large US public companies, both within and outside the healthcare industry, will be a valuable addition to our board.'